NCT05709210 Pilot Study on the Feasibility of Using Smartphone Data as a Diagnostic Marker for Alzheimer's Disease
| NCT ID | NCT05709210 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Poitiers University Hospital |
| Condition | Alzheimer Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2023-07-20 |
| Primary Completion | 2026-10-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2023-07-20 with a primary completion date of 2026-10-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will compare smartphone usage data between three groups of patients diagnosed with either a memory complaint, mild cognitive decline, or Alzheimer's disease.
Eligibility Criteria
Inclusion Criteria: * Patient consulting in routine care in one of the CMRR * No sensory impairment that may compromise smartphone use Exclusion Criteria: * Inability to perform MMSE or MMSE \< 20 ; * Other neurodegenerative condition (Parkinson's disease, Lewy body disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis) * Severe anxiety or depressive disorder HADS score ≥ 17 * Terminal phase of a severe disease * Evidence of a lesion on MRI that may be involved in cognitive impairment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05709210 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Alzheimer Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05709210 currently recruiting?
Yes, NCT05709210 is actively recruiting participants. Contact the research team at adrien.julian@chu-poitiers.fr for enrollment information.
Where is the NCT05709210 trial being conducted?
This trial is being conducted at Poitiers, France.
Who is sponsoring the NCT05709210 clinical trial?
NCT05709210 is sponsored by Poitiers University Hospital. The trial plans to enroll 90 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.